STAG3L5P: A Potential Drug Target and Biomarker (G101735302)

Target Name: STAG3L5P

NCBI ID: G101735302

STAG3L5P

Other Name(s): Stromal antigen 3-like 5 pseudogene | stromal antigen 3-like 5 pseudogene

STAG3L5P: A Potential Drug Target and Biomarker

Stag3l5p is a protein that is expressed in various tissues of the body, including the brain, pancreas, and muscle. Its full name is scaffold-associated protein GTPase-3 (Stag) 5 (L5) protein. It is a member of the GTPase family of proteins, which are known for their ability to regulate the binding of nucleotides to RNA-protein complexes. STAG3l5p is unique due to its structure and the unique functions it is known to have.

One of the unique features of STAG3l5p is its ability to interact with small molecules, such as drug molecules. This protein has been shown to play a role in the regulation of gene expression and has been identified as a potential drug target. The ability of STAG3l5p to interact with small molecules also makes it a potential biomarker for certain diseases.

The discovery and characterization of STAG3l5p was made by a team of researchers at the University of California, San Diego. The researchers identified STAG3l5p as a protein that was expressed in a variety of tissues and were able to use RNA interference techniques to knockdown the expression of the protein in certain cells. They found that when the expression of STAG3l5p was knocked down, the cells were able to survive for longer periods of time in the presence of certain stresses, such as starvation or radiation.

The researchers also found that when the expression of STAG3l5p was turned up, the cells were able to survive for shorter periods of time in the presence of these stresses. This suggests that STAG3l5p may have a role in the regulation of cell survival and that it may be a potential drug target.

In addition to its role in cell survival, STAG3l5p has also been shown to play a role in the regulation of inflammation. The researchers found that when the expression of STAG3l5p was turned up, the cells were able to produce more reactive oxygen species (ROS), which are known to contribute to inflammation. This suggests that STAG3l5p may have a role in the regulation of inflammation and that it may be a potential biomarker for certain inflammatory diseases.

The ability of STAG3l5p to interact with small molecules also makes it a potential drug target. The researchers have identified a number of small molecules that have been shown to interact with STAG3l5p and have found that some of these molecules are able to inhibit the activity of the protein. This suggests that a small molecule-based therapy may be a promising approach for treating certain diseases.

In conclusion, STAG3l5p is a protein that has been identified as a potential drug target and biomarker. Its unique structure and the functions it is known to have make it an attractive target for small molecule-based therapies. Further research is needed to fully understand the role of STAG3l5p in the regulation of cell survival, inflammation, and other processes.

Protein Name: Stromal Antigen 3-like 5 Pseudogene

The "STAG3L5P Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about STAG3L5P comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets